Permanently Discontinued

JAMP-RIZATRIPTAN IR

JAMP PHARMA CORPORATION

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is JAMP-RIZATRIPTAN IR discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that JAMP-RIZATRIPTAN IR 5MG has been permanently discontinued (last updated December 21, 2021). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is JAMP-RIZATRIPTAN IR not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

Can I still get this?Check with your pharmacist — only products with a different form or route found

StatusPermanently Discontinued

Same-ingredient products on file6 products · 0 same form & route

Affected strength5MG

Report last updated2021-12-21

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

MAXALT RPD

ORGANON CANADA INC.

5MG · DIN 02240518

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

RIZATRIPTAN ODT

SIVEM PHARMACEUTICALS ULC

5MG · DIN 02446111

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

MAR-RIZATRIPTAN ODT

MARCAN PHARMACEUTICALS INC

5MG · DIN 02462788

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

RIZATRIPTAN RDT

PRO DOC LIMITEE

5MG · DIN 02415798

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

TEVA-RIZATRIPTAN ODT

TEVA CANADA LIMITED

5MG · DIN 02396661

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

MAXALT

ORGANON CANADA INC.

10MG · DIN 02240521

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02429233

Strength

5MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

RIZATRIPTAN

See all RIZATRIPTAN products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

Active Shortage

Disruption of the manufacture of the drug.

Other Products from JAMP PHARMA CORPORATION

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACTIVATED CHARCOAL

225MG · DIN 02420694

AMIKACIN SULFATE INJECTION

250MG · DIN 02529459

AMIODARONE HYDROCHLORIDE FOR INJECTION

50MG · DIN 02423227

5MG · DIN 02429217

10MG · DIN 02429225

2.5MG · DIN 02492199

DIN 02532174

DIN 02532182

AZITHROMYCIN FOR INJECTION

500MG · DIN 02523825

BACLOFEN INJECTION USP

2MG · DIN 02553341

BENDAMUSTINE HYDROCHLORIDE FOR INJECTION

100MG · DIN 02509172

BENDAMUSTINE HYDROCHLORIDE FOR INJECTION

25MG · DIN 02509164